LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,416,095
تعداد دریافت فایل اصل مقاله11,291,797
Bahramian, Ayla, Motahari, Paria, Hanifenezhad, Aliraza. (1403). Expression of Ki-67 in Oral Lichen Planus: A Systematic Review and Meta-Analysis. سامانه مدیریت نشریات علمی, 25(4), 288-295. doi: 10.30476/dentjods.2023.98491.2082
Ayla Bahramian; Paria Motahari; Aliraza Hanifenezhad. "Expression of Ki-67 in Oral Lichen Planus: A Systematic Review and Meta-Analysis". سامانه مدیریت نشریات علمی, 25, 4, 1403, 288-295. doi: 10.30476/dentjods.2023.98491.2082
Bahramian, Ayla, Motahari, Paria, Hanifenezhad, Aliraza. (1403). 'Expression of Ki-67 in Oral Lichen Planus: A Systematic Review and Meta-Analysis', سامانه مدیریت نشریات علمی, 25(4), pp. 288-295. doi: 10.30476/dentjods.2023.98491.2082
Bahramian, Ayla, Motahari, Paria, Hanifenezhad, Aliraza. Expression of Ki-67 in Oral Lichen Planus: A Systematic Review and Meta-Analysis. سامانه مدیریت نشریات علمی, 1403; 25(4): 288-295. doi: 10.30476/dentjods.2023.98491.2082

Expression of Ki-67 in Oral Lichen Planus: A Systematic Review and Meta-Analysis

Journal of Dentistry
مقاله 1، دوره 25، شماره 4 - شماره پیاپی 85، اسفند 2024، صفحه 288-295    اصل مقاله (500.89 K)
نوع مقاله: Systematic Review
شناسه دیجیتال (DOI): 10.30476/dentjods.2023.98491.2082
نویسندگان
Ayla Bahramian1؛ Paria Motahari* 1؛ Aliraza Hanifenezhad2
1Dept. of Oral and Maxillofacial Medicine, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
2Dental Student, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
چکیده
Statement of the Problem: One of the main signs of cancer development is increasing of cell proliferation activity. Expression of the Ki-67 as a cell proliferation marker is extensively utilized in pathology studies as an indicator of proliferation in human tumors. According to studies, Ki-67 plays an effective role in the pathology of malignant and pre-malignant oral mucosa lesions.
Purpose: The current study aimed to systematically review the Ki-67 expression in oral lichen planus without dysplasia and compare it with oral epithelial dysplasia.
Materials and Method: In this meta-analysis, all articles in the English language were searched in databases including Web of Science, PubMed, Embase, Scopus, and Google Scholar until July 2023. MeSH terms and free keywords were used in the search step. Expression of Ki-67 in oral lichen planus and oral epithelial dysplasia was analyzed by Comprehensive Meta-Analysis software.
Results: Nine hundred and two articles related to the searched words were found. According to the selection criteria, 12 retrospective articles were selected. Low quality was not observed in any of the records by the Newcastle-Ottawa scale and most of them had a relatively good quality. Totally, 593 patients were examined. The heterogeneity between studies was not significant. The meta-analysis results indicated a significantly lower Ki-67 expression in oral lichen planus without dysplasia in comparison to oral epithelial dysplasia.
Conclusion: The more intense expression level of Ki-67 in oral epithelial dysplasia compared with oral lichen planus was observed. The ki-67 expression could be utilized to indicate the existence and intensity of epithelial dysplasia and disease progression. 
کلیدواژه‌ها
Ki-67 antigen؛ Lichen planus؛ Oral؛ Prognosis
سایر فایل های مرتبط با مقاله
مراجع
  • Mehrbani SP, Motahari P, Azar FP, Ahari MA. Role of interleukin-4 in pathogenesis of oral lichen planus: A systematic review. Med Oral Patol Oral Cir Bucal. 2020; 25: e410-e415.
  • Gholizadeh N, Mehdipour M, Dadgar E, Bahramian A, Moghaddas DE. Immunohistochemical Evaluation of Ki-67 Expression in Erosive and Non-Erosive Oral Lichen Planus. Avicenna J Dent Res. 2016; 8: 1.
  • Motahari P, Pournaghi Azar F, Rasouly P. Association of interferon-gamma gene polymorphism (+874 A/T) and oral lichen planus susceptibility: Systematic review and meta-analysis. Jorjani Biomed J. 2019; 7: 45-55.
  • Sugerman PB, Sabage N. Oral lichen planus: causes, diagnosis and management. Aust Dent J. 2002; 47: 290-297.
  • Motahari P, Pournaghi Azar F, Rasi A. Role of vitamin D and vitamin D receptor in oral lichen planus: A systematic review. Ethiop J Health Sci. 2020; 30: 615-622.
  • Warnakulasuriya S, Johnson NW, Van*der*Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007; 36: 575-580.
  • Barnard N, Scully C, Eveson J, Cunningham S, Porter S. Oral cancer development in patients with oral lichen planus. J Oral Pathol Med. 1993; 22: 421-424.
  • Liu Y, Messadi DV, Wu H, Hu S. Oral lichen planus is a unique disease model for studying chronic inflammation and oral cancer. Med Hypotheses. 2010; 75: 492-494.
  • Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. 2002; 46: 207-214.
  • Larsson A, Warfvinge G. Malignant transformation of oral lichen planus. Oral Oncol. 2003; 39: 630-631.
  • Acay RR, Felizzola CR, de Araújo NS, de Sousa SOM. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67. Oral Oncol. 2006; 42: 475-480.
  • Moltajaei MH, Pourzare Mehrbani S, Motahari P, Rezapour R. Clinicopathological and prognostic value of Ki-67 expression in oral malignant melanoma: A systematic review and meta-analysis. J Dent Res Dent Clin Dent Prospects. 2022; 16: 140-146.
  • Bashardoust N, Modabbernia S, Bagheri S, Shiva A, Jalali R. Immunohistochemical analysis of Ki-67 expression in oral lichen planus lesions. J Dentomaxillofac. 2015; 4: 25-30.
  • Pigatti FM, Taveira LAdA, Soares CT. Immunohistochemical expression of B cl‐2 and K i‐67 in oral lichen planus and leukoplakia with different degrees of dysplasia. Int J Dermatol. 2015; 54: 150-155.
  • Kumar KV, Chaithanya K, Punde P, Thorat A, Jangam AG, Deepthi S. Comparative evaluation of imunohistochemical expression of Ki-67 in oral lichen planus, oral leukoplakia and normal mucosa cases. J Int Oral Health. 2015; 7: 82-87.
  • Mattila R, Alanen K, Syrjänen S. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions. Arch Dermatol Res. 2007; 298: 381-388.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25: 603-605.
  • Garcia-Pola Vallejo MG, Roldán MJA, Alvarez BEF, Martín JMG, López-Muñiz A. Study comparative of Ki-67 expression in oral lichen planus and oral leukoplakia. Quantitative analysis. Med Oral. 2001; 6: 364-370.
  • Girod SC, Pfeiffer P, Ries J, Pape HD. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 1998; 36: 252-260.
  • Idrees M, Shearston K, Farah CS, Kujan O. Immunoexpression of oral brush biopsy enhances the accuracy of diagnosis for oral lichen planus and lichenoid lesions. J Oral Pathol Med. 2022; 51: 563-572.
  • Mittal A, Awasthi S, Chauhan R, Ahmad F, Kumar A, Mitra N. Ki-67 expression in oral potential malignant and malignant lesions and correlation of mitotic index with MIB-1 labeling index. Acta Med Int. 2022; 9: 14-20.
  • Ono J, Okada Y, Kanri Y, Sano H, Hasegawa H. Immunohistochemical study of differential expressions of CAR, E-Cadherin, CK-13, -17, p53 and Ki-67 in oral lichen planus, lichenoid lesion and lichenoid epithelial dysplasia. J Hard Tissue Biol. 2021; 30: 355-362.
  • Raju B, Mehrotra R, Oijordsbakken G, Al-Sharabi AK, Vasstrand EN, Ibrahim SO. Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters. Anticancer Res. 2005; 25: 4699-4706.
  • Rosa EA, Hurtado Puerto AM, Falcão DP, Brietzke AP, de Almeida Prado Franceschi LE, Cavalcanti Neto FF, et al. Oral lichen planus and malignant transformation: The role of p16, Ki-67, Bub-3 and SOX4 in assessing precancerous potential. Exp Ther Med. 2018; 15: 4157-4166.
  • Shailaja G, Kumar JV, Baghirath PV, Kumar U, Ashalata G, Krishna AB. Estimation of malignant transformation rate in cases of oral epithelial dysplasia and lichen planus using immunohistochemical expression of Ki-67, p53, B-CL-2, and BAX markers. Dent Res J. 2015; 12: 235-242.
  • Zargaran M, Jamshidi SH, Eshghyar N, Moghimbeigi A. Suitability/unsuitability of cell proliferation as an indicator of malignant potential in oral lichen planus: an Immunohistochemical study. Asian Pac J Cancer Prev. 2013; 14: 6979-6983.
  • Sanketh DS, Kumari K, Rao RS, Haragannavar VC, Sarode SC, Sarode GS, et al. Expression of Ki-67, p53, α-SMA and COX-2 in lichen planus and related lesions: A pilot study. J Oral Biol Craniofac Res. 2019; 9: 230-235.
  • Pirkic A, Dolores BL, Cekic-Aramba A, Bukovic D, Habek M, Hojsak I. Tissue expression of proliferative antigens (PCNA and Ki-67) in oral lichen ruber related to clinical status. Coll Antropol. 2004; 24: 447–453.
  • Li LT, Jiang G, Chen Q, Zheng JN. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep. 2015; 11: 1566-1572.
  • Carinci F, Lo Muzio L, Piattelli A, Rubini C, Palmieri A, Stabellini G, et al. Genetic portrait of mild and severe lingual dysplasia. Oral Oncol. 2005; 41: 365–374.
  • Takkem A, Barakat C, Zakaraia S, Zaid K, Najmeh J, Ayoub M, et al. Ki-67 Prognostic value in different histological grades of oral epithelial dysplasia and oral squamous cell carcinoma. Asian Pac J Cancer Prev. 2018; 19: 3279-3286.
  • Suwasini S, Chatterjee K, Purkait SK, Samaddar D, Chatterjee A, Kumar M. Expression of P53 Protein and Ki-67 Antigen in Oral Leukoplakia with Different Histopathological Grades of Epithelial Dysplasia. J Int Soc Prev Community Dent. 2018; 8: 513-522.
  • Odell E, Kujan O, Warnakulasuriya S, Sloan P. Oral epithelial dysplasia: Recognition, grading and clinical significance. Oral Dis. 2021; 27: 1947-1976.
  • Woo SB. Oral Epithelial Dysplasia and Premalignancy. Head Neck Pathol. 2019; 13: 423-439.
  • Georgakopoulou EA, Achtari MD, Achtaris M, Foukas PG, Kotsinas A. Oral lichen planus as a preneoplastic inflammatory model. J Biomed Biotechnol. 2012; 2012: 759626.
  • Tatullo M, Marrelli M, Amantea M, Paduano F, Santacroce L, Gentile S, et al. Bioimpedance detection of oral lichen planus used as preneoplastic model. J Cancer. 2015; 6: 976-983.
  • Edwards PC. Is it time to extend synoptic reporting to include potentially preneoplastic oral epithelial and lichenoid lesions? Oral Surg Oral Med Oral Pathol Oral Radiol. 2017; 124: 105-110.
  • Bascones-Ilundain C, González-Moles MA, Campo-Tra-pero J, Gil-Montoya JA, Esparza-Gómez GC, Cano-Sán-chez J, et al. No differences in caspase-3 and Bax expression in atrophicerosive vs. reticular oral lichen planus. J Eur Acad Dermatol Venereol. 2008; 22: 204-212.
آمار
تعداد مشاهده مقاله: 2,878
تعداد دریافت فایل اصل مقاله: 317


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب